TAMIKO D'ELENA: Open Payments
NPI 1164503108 · JOHNS CREEK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,149 in 111 payments from 21 companies in 2025. Trend: 2023 $1,246 · 2024 $1,638 · 2025 $4,149
Food & beverage: $4,050Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $647 |
| ABBVIE INC. | 25 | $647 |
| Madrigal Pharmaceuticals | 9 | $491 |
| Ardelyx, Inc. | 10 | $335 |
| Regeneron Healthcare Solutions, Inc. | 9 | $324 |
| Gilead Sciences, Inc. | 2 | $242 |
| PFIZER INC. | 9 | $188 |
| GENZYME CORPORATION | 6 | $161 |
| Aimmune Therapeutics, Inc. | 6 | $145 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $134 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, DUPIXENT, IBSRELA, VELSIPITY, RINVOQ, ZENPEP.
Industry payments across GA — which companies pay providers there.
